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H I G H L I G H T S
• Most polymer gel dosimeters have acceptable dose accuracy.
• Acrylamide-based gel dosimeters are highly toxic.
• The dose response of methacrylic acid–based gel dosimeters is beam energy dependent.
• The sensitivity of N-isopropylacrylamide gel dosimeters is lower.
• It is diﬃcult to judge which is the best polymer gel dosimeter to use in the clinic.
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A B S T R A C T
Radiotherapy has rapidly improved because of the use of new equipment and techniques. Hence, the appeal for a
feasible and accurate three-dimensional (3D) dosimetry system has increased. In this regard, gel dosimetry
systems are accurate 3D dosimeters with high resolution. This systematic review evaluates the clinical appli-
cations of polymer gel dosimeters in radiotherapy. To ﬁnd the clinical applications of polymer gel dosimeters in
radiotherapy, a full systematic literature search was performed on the basis of the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines in electronic databases up to January 31, 2017,
with use of search-related terms in the titles and abstracts of articles. A total of 765 articles were screened in
accordance with our inclusion and exclusion criteria. Eventually, 53 articles were included in the study. The
ﬁndings show that most clinical applications of polymer gel dosimeters relate to external radiotherapy. Most of
the gel dosimeters studied have acceptable dose accuracy as a 3D dosimeter with high resolution. It is diﬃcult to
judge which is the best polymer gel dosimeter to use in a clinical setting, because each gel dosimeter has
advantages and limitations. For example, methacrylic acid–based gel dosimeters have high dose sensitivity and
low toxicity, while their dose response is beam energy dependent; in contrast, N-isopropylacrylamide gel do-
simeters have low dose resolution, but their sensitivity is lower and they are relatively toxic.
1. Introduction
The purpose of radiotherapy is to cover the tumor tissue homo-
geneously with an adequate dose while minimizing the dose to the
surrounding normal tissue (Mann et al., 2017; Tanha et al., 2014). At
present, applied techniques in radiation oncology can deliver a dose
distribution with high conformity and precision to the treatment target
volume (Novotny et al., 2001). It is noteworthy that any error or
inaccuracy in dose delivery during irradiation in these modern tech-
niques can result in either an insuﬃcient dose to the tumor tissue or a
high dose to the adjacent vital organs (Abtahi et al., 2016). Hence, the
determination of the three-dimensional (3D) dose distribution in a
tissue-equivalent material, before radiotherapy, can decrease any pos-
sible error (Abtahi et al., 2016).
To verify the dose distributions resulting from modern radiotherapy
techniques, a dosimeter is needed to accurately measure 3D dose
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distributions with high spatial resolution (Hilts et al., 2000). In clinical
radiotherapy, the use of gel dosimeters can help in the high-resolution
and precise veriﬁcation of 3D dose distributions obtained by treatment
planning facilities, while most current dosimeters measure the dose in
one or two dimensions only (such as thermoluminescent dosimeters,
ionization chamber–based dosimeters, and radiographic ﬁlm–based
dosimeters) (Senden et al., 2006). Polymer gel dosimeters are con-
structed from chemical materials that are sensitive to radiation and are
polymerized as a function of the absorbed dose on irradiation (Abtahi
et al., 2014). Radiation induces structural changes in the diﬀerent
polymer gel dosimeters that can aﬀect their properties, such as varia-
tion in the proton nuclear magnetic resonance relaxation times, mass
density, opacity, and elasticity (Senden et al., 2006). These character-
istics can be read out by magnetic resonance imaging (MRI) (Maryanski
et al., 1993), x-ray computed tomography (CT) (Hilts et al., 2000),
optical scanning (Maryanski et al., 1996a), and ultrasonography
(Mather et al., 2002). Gel dosimetry has advantageous properties that
can simplify radiotherapy dosimetry, particularly in conditions in
which conventional dosimeters cannot be used (Ibbott, 2004). These
characteristics consist of the capability of measuring complex 3D dose
distributions; radiological tissue equivalence; radiation direction in-
dependency; high spatial resolution; integration of dose during a
treatment; etc. (Abtahi et al., 2014, 2016). In addition, gel dosimeters
are relatively safe to fabricate and handle, although there are some
toxic components, such as acrylamide, that must be applied with ap-
propriate protection (Ibbott, 2004).
The applications of gel dosimeters include basic dosimetry such as
depth dose, penumbra, and wedge proﬁles in diﬀerent types of beams;
dose distributions from various imaging procedures; dose distribution
from diﬀerent radiotherapy techniques, such as conformal therapy,
intensity-modulated radiotherapy (IMRT), and stereotactic radio-
surgery; dose distributions around various brachytherapy sources; and
assessment of tissue heterogeneities such as bone and air.
In this systematic review, we study clinical application of polymer
gel dosimeters in radiotherapy. In addition, we try to answer the fol-
lowing questions: What features of polymer gel dosimeters are im-
portant for clinical applications? What are the characteristics of dif-
ferent polymer gel dosimeters? What are the advantages and limitations
of diﬀerent polymer gel dosimeters relative to each other? What is the
best polymer gel dosimeter to use in the clinic?
2. Methods
2.1. Search strategy
This systematic review was designed on the basis of the 2009
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines (Moher et al., 2009). A literature search was
conducted to assess all available studies in electronic databases, in-
cluding Scopus, PubMed, Embase, and Web of Science, up to October
31, 2017, by use of the following search terms in titles and abstracts:
“polymer gel”; and “radiation therapy” or “radiotherapy” or “external
radiation therapy” or “external radiotherapy” or “brachytherapy” or
“neutron capture therapy” or “NCT” or “BNCT”; and “BANANA” or
“BANG” or “PAG” or “MAG” or “MAGIC” or “MAGAT” or “PAGAS” or
“MAGAS” or “PAGAT” or “NIPAM” or “N-isopropylacrylamide” or
“MAGIC-A” or “MAGIC-f” or “VIPAR” or “PABIG” or “LMD” or “PAM-
PSGAT” or “PAGATUG” or “PVA-BAT.”
2.2. Study selection
Original articles were included that met the following inclusion
criteria: (a) studies that used a combination of “polymer gel” and other
search terms; (b) studies with full-text articles; (c) studies with ade-
quate information; (d) studies in English. The exclusion criteria in-
cluded (a) studies with unrelated abstracts, (b) studies with incomplete
data on the clinical application of polymer gel dosimeters in radio-
therapy, (c) studies presented as a poster, (d) letters to the editor, (e)
editorials, and (f) review articles.
2.3. Data extraction
Each eligible article was reviewed, and the following information
was extracted: (a) authors’ names; (b) polymer gel dosimeter type; (c)
beam type (photon, electron, and/or neutron); (d) radiotherapeutic
treatment type (external radiotherapy, brachytherapy, and/or boron
neutron capture therapy [BNCT]); (e) clinical application type; (f)
therapeutic technique type; (g) readout system type of the polymer gel
dosimeter (MRI, optical CT, and/or x-ray CT); and (h) outcomes related
to the use of polymer gel dosimeters in radiotherapy for clinical ap-
plications.
3. Results
3.1. Literature search
The study selection process is illustrated in Fig. 1.
Our initial search in the aforementioned databases up to November
1, 2017, identiﬁed 765 articles. After exclusion of duplicates, the
numbers of articles were reduced to 407. After screening, 261 articles
were excluded by checking the titles and abstracts of the articles, and
146 articles were qualiﬁed for full-text analysis. Then, studies with
missing data or compliance studies with exclusion criteria were dis-
carded. Finally, 53 articles were included in the systematic review. The
extracted data and characteristics of the 53 articles are summarized in
Table 1.
3.2. Clinical applications of polymer gel dosimeters
Diﬀerent clinical applications of polymer gel dosimeters will be
presented in three distinct sections, including external beam radio-
therapy, brachytherapy, and BNCT. Because of the large number of
studies, some are discussed in the following sections and the remaining
studies not discussed are listed in Table 1.
3.2.1. External beam radiotherapy
Most clinical applications of polymer gel dosimeters relate to
Fig. 1. Flowchart of the study selection process.
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external beam radiotherapy. With the advent of complex and precise
radiotherapeutic techniques such as IMRT, volumetric modulated arc
therapy (VMAT), and stereotactic radiosurgery, the demand for an ac-
curate and feasible 3D dosimetry system such as a gel dosimeter has
increased (Khezerloo et al., 2017).
In 1998, Oldham et al. used a BANG gel dosimeter for dosimetric
evaluation of nine-ﬁeld tomotherapy irradiation. This treatment plan-
ning simulated a prostate treatment. They found that the gel dosimeter
provided good agreement with dose distributions predicted by a treat-
ment planning system (TPS) at medium and high doses (50–90%
Table 1
Characteristics of included studies.
Author and year Gel type Beam type Treatment type Technique type Readout
system
Clinical application
Oldham et al. (1998) BANG Photon External IMRT MRI Prostate
De Deene et al. (1998) BANG Photon External Conformal (non-IMRT) MRI Head and neck
Farajollahi et al. (1999) BANG 137Cs Brachytherapy – MRI Complex gynecological insertion
Hepworth et al. (1999) BANG and
PAG
Photon External Non-IMRT MRI Inhomogeneity (bone and air)
McJury et al. (1999) PAG 192Ir Brachytherapy – MRI Bronchus catheter
Meeks et al. (1999) BANG Photon External Stereotactic radiosurgery/
radiotherapy
MRI Acoustic schwannomas
Cosgrove et al. (2000) PAG Photon External Stereotactic conformal MRI Benign tumor located in near the left
eye and optic nerve
Chan et al. (2000) BANG 106Ru Brachytherapy – MRI Eye
Wojnecki and Green (2001) PAG Neutron BNCT – MRI Brain
Amin et al. (2003) PAG 90Sr/90Y Brachytherapy Intravascular MRI Curved coronary artery
Wuu et al., (2002, 2003) BANG 188Re Brachytherapy Intravascular Optical CT Coronary vessel wall
Guillerminet et al. (2003) PAG Photon External Non-IMRT MRI Inhomogeneity (bone)
Gustavsson et al. (2003) MAGIC Photon External Non-IMRT MRI Kidney-shaped target
Kipouros et al. (2003) VIPAR 192Ir Brachytherapy Monotherapy MRI Prostate
Uusi-Simola et al. (2003) BANG-3 Neutron BNCT – MRI Brain
Trapp et al. (2004) MAGIC Photon and
electron
External Non-IMRT and IMRT MRI Carcinoma of the scalp
Watanabe et al. (2004) BANG-3 Photon External Stereotactic radiosurgery MRI Inhomogeneity (bone and air)
Xu et al. (2004) BANG-3 Photon External Non-IMRT Optical CT Brain
Giﬀord et al. (2005) MAGIC 137Cs Brachytherapy Intracavity MRI Cervical cancer
Gambarini et al. (2006) PAG Neutron BNCT – MRI Liver
Ravichander et al. (2006) PAGAT Photon External Non-IMRT MRI Head and neck ﬁeld matching
Wuu and Xu (2006) BANG-3 Photon External IMRT Optical CT Small brain tumor
Lopatiuk-Tirpak et al. (2008) BANG-3 Photon External Non-IMRT Optical CT Lung
Baker et al. (2009) BANG-1 Photon External Non-IMRT MRI Ocular tumors
Kozicki et al. (2009) VIPAR Photon External Non-IMRT MRI Brain tumor
Marques et al. (2009) MAGIC-f 192Ir Brachytherapy – MRI Esophagus
Pourfallah et al. (2009) PAGAT Photon External Stereotactic radiosurgery MRI Inhomogeneity (bone and air)
Toossi et al. (2009) MAGAT Photon External Non-IMRT MRI Bladder cancer
Marques et al. (2010) MAGIC-f Photon External Non-IMRT MRI Gold nanoparticles
Gopishankar et al. (2012) MAGAT Photon External Stereotactic radiosurgery MRI Pituitary adenoma
Kairn et al. (2012) PAGAT Photon External Stereotactic radiotherapy Optical CT Meningioma
Pavoni et al. (2012) MAGIC-f Photon External Tomotherapy MRI Prostate
Fazli et al. (2013) MAGIC-A 192Ir Brachytherapy – MRI Nasopharynx
Gopishankar et al. (2013) MAGAT Photon External IMRT MRI Spinal metastasis target
Govi et al. (2013) MAGAT 192Ir Brachytherapy – MRI Breast balloon
Khadem-Abolfazli et al.
(2013)
MAGIC-A Photon External Non-IMRT MRI Gold nanoparticles
Chen et al. (2014) NIPAM Photon External IMRT MRI Eye
Da Silveira et al. (2014) MAGIC-f Photon External IMRT MRI Prostate
Deyhimihaghighi et al.
(2014)
PAGAT Photon External Non-IMRT MRI Platinum nanoparticles
Fuse et al. (2015) BANG-Pro Photon External Non-IMRT MRI Breast conserving therapy and bolus
compensator
Kakade and Sharma (2015) PAGAT Photon External Non-IMRT MRI Prostate and gold nanoparticles
Cuevas et al. (2016) MAGIC-f Photon External IMRT MRI Prostate
Khosravi et al. (2015) MAGIC-f Photon and
192Ir
External and
brachytherapy
Non-IMRT MRI Prostate and gold nanoparticles
Cheng et al. (2016) NIPAM Photon External IMRT MRI Eye
Khosravi et al. (2016) MAGIC-f 192Ir Brachytherapy Non-IMRT MRI Prostate and gold nanoparticles
Bavarnegin et al. (2017) NIPAM Neutron BNCT – MRI Brain
Hsieh et al. (2017) NIPAM Photon External IMRT MRI Intracranial meningioma
Khajeali et al. (2017) NIPAM Neutron BNCT – MRI Shallow brain tumors
Ghaseminejad et al. (2017) NIPAM Photon External IMRT MRI Inhomogeneity (bone)
Mann et al. (2017) PAGAT Photon External Adaptive radiotherapy MRI Lung
Silveira et al. (2017) MAGIC-f Photon External IMRT MRI Prostate
Yao et al. (2017) NIPAM Photon External VMAT and IMRT Optical CT Lung and larynx
BNCT, boron neutron capture therapy; CT, computed tomography; IMRT intensity-modulated radiotherapy; MAGAT, methacrylic acid, gelatin, and tetrakis(hy-
droxymethyl)phosphonium chloride; MAGIC, methacrylic acid, ascorbic acid, gelatin, and copper; MAGIC-A, methacrylic acid, ascorbic acid, gelatin, copper, and
agarose; MAGIC-f, methacrylic acid, ascorbic acid, gelatin, copper, and formaldehyde; MRI, magnetic resonance imaging; NIPAM, N-isopropylacrylamide; PAG,
polyacrylamide gel; PAGAT, polyacrylamide, gelatin, and tetrakis(hydroxymethyl)phosphonium chloride; VIPAR, N-vinylpyrrolidone-argon; VMAT, volumetric
modulated arc therapy.
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isodose), although diﬀerences were observed at lower doses (30% iso-
dose) up to 10%. They concluded that the BANG gel dosimeter has the
potential to verify IMRT dose distributions; however, considerable care
is needed to achieve accurate results (Oldham et al., 1998). Cosgrove
et al. assessed the reproducibility of a polyacrylamide gel (PAG) dosi-
meter in stereotactic conformal radiotherapy. The plans used in their
study were three coplanar ﬁelds and four non-coplanar ﬁelds. The beam
geometry of the second plan was used for treatment of a benign tumor
located near the left eye and optic nerve. They reported the relative
dose distributions can be reproducible, with the standard deviation on
the mean regions with higher than the 50% isodose curves obtained in
three orthogonal ﬁelds being 4.1% and 6.4% for the non-coplanar and
coplanar ﬁelds, respectively. Furthermore, the measured dose dis-
tributions were in line with those calculated by the TPS. Finally, they
concluded that despite the limitations of the PAG dosimetry technique,
especially for calibration of dose distributions to absolute dose, it is
capable of verifying complex conformal treatment plans (Cosgrove
et al., 2000). Trapp et al. used a methacrylic acid, ascorbic acid, gelatin,
and copper (MAGIC) gel dosimeter for veriﬁcation of photon and
electron treatment plans in carcinoma of the scalp. In electron ﬁelds,
their ﬁndings showed that the gel and diode data were generally in
good agreement, with a small diﬀerence in the buildup region. Also, for
IMRT ﬁelds, the isodose contours generated by the TPS were in good
agreement with those measured by the gel dosimeter. Finally, the re-
sults from this study demonstrate that the use of gel dosimetry has
become a beneﬁcial dosimetric tool in radiotherapy (Trapp et al.,
2004). Ravichander et al. used a polyacrylamide, gelatin, and tetrakis
(hydroxymethyl)phosphonium chloride (PAGAT) gel dosimeter for
head and neck ﬁeld matching veriﬁcation. In this study, the full width
at half maximum through the nondiverging orthogonal head and neck
ﬁeld junction was determined with ﬁlm, the gel dosimeter, and the TPS.
The full width at half maximum diﬀerence between the PAGAT polymer
gel and the ﬁlm was within 0.5 mm. Furthermore, the maximum dif-
ference between gel dosimeter and Pinnacle TPS proﬁles was 7%. They
stated that these diﬀerences are related to several factors, such as the
detector size used for calculation of the proﬁles in the Pinnacle TPS and
CT voxel limitation (Ravichander et al., 2006). Kozicki et al. evaluated
application of the VIPARnd-GeVero® tool in a brain tumor radiotherapy.
In this study, the software program GeVero® was used to process
polymer gel data obtained from MRI, and the ﬁndings were compared
with the dose distribution calculated by the TPS. Their results showed
satisfactory agreement between VIPARnd gel dosimetry and TPS dose
distributions. In addition, the usefulness of GeVero® and the VIPARnd
gel dosimeter was proved in radiotherapy dosimetry. It was also shown
that this software facilitates data processing (Kozicki et al., 2009).
Gopishankar et al. investigated the accuracy of a source plugging–based
treatment plan in Gamma Knife stereotactic radiosurgery by using a
methacrylic acid, gelatin, and tetrakis(hydroxymethyl)phosphonium
chloride (MAGAT) gel dosimeter and EBT2 ﬁlm. In this study, a Y-
shaped target and two organs at risk on either side of the target were
created; this beam geometry simulates a pituitary adenoma tumor with
optic nerves on either side. For 80% and 50% isodose curves, there
were distance agreements of 2mm and 1mm, respectively, between gel
measurements and TPS calculations. Furthermore, the results related to
3D gamma index analysis demonstrated a more than 94% voxel pass
rate for tolerance criteria of 2%/2mm, 3%/1mm, and 3%/2mm. In
conclusion, they suggested that a MAGAT gel dosimeter can be used for
veriﬁcation of plug-based treatment planning (Gopishankar et al.,
2012). Kairn et al. veriﬁed the PAGAT gel dosimeter response in ac-
curate, high-resolution, 3D dose measurements of stereotactic radio-
therapy ﬁelds by using Monte Carlo simulations. In this study, a small
cylindrical container was ﬁlled with the PAGAT gel and located in the
parietal region within a heterogeneous head phantom and then irra-
diated with a 12-ﬁeld, non-coplanar, conformal stereotactic radio-
therapy plan. They copied this beam geometry from a meningioma
patient plan. The dose distributions obtained from the gel measurement
and Monte Carlo simulations were in better agreement with each other
than with those calculated by pencil beam TPS. Both data sets (gel
dosimeter and Monte Carlo simulations) demonstrated close agreement
with the TPS calculations through the center of the irradiated volume.
However, the dose distributions obtained from Monte Carlo simulations
and the gel dosimeter had subtle dose variations and narrower beam
penumbrae than those from TPS calculations. In conclusion, the Monte
Carlo data allowed the accuracy of the PAGAT gel dosimeter to be
veriﬁed, allowing the PAGAT gel dosimeter to be used in the mea-
surement of the dose from stereotactic radiotherapy and other types of
radiotherapy (Kairn et al., 2012). Gopishankar et al. used a multi-
purpose acrylic head phantom to verify IMRT planning by using
MAGAT gel and ﬁlm dosimetry. They delineated a planning target vo-
lume of a doughnut shape along with an inner organ at risk for IMRT
planning, as this plan simulates a spinal metastasis target. For this
purpose, a nine-ﬁeld IMRT plan was designed with the Pinnacle TPS.
Three-dimensional gamma index analysis between the measured gel
dose and the calculated TPS dose demonstrated a higher than 90%
voxel pass rate for tolerance criteria of 1%/1mm and 2%/2mm. Fi-
nally, they reported that gel dosimetry has the potential to extract 3D
dosimetric data in routine clinical applications (Gopishankar et al.,
2013). Silveira et al. compared the results of 3D dosimetry with a gel
dosimeter based on MAGIC with formaldehyde added (MAGIC-f) with
those of conventional quality assurance procedures of one- and two-
dimensional dosimetry in prostate cancer IMRT planning. In this study,
a gamma index of 3%/3mm was used to compare the 3D measurements
of the gel dosimeter and the dose distributions obtained from the TPS.
The gel dosimetry ﬁndings agreed with those of the conventional
quality control procedures. Finally, they concluded that a MAGIC-f gel
dosimeter associated with MRI can be used to evaluate the dose dis-
tribution in 3D quality control. In addition, it allows volumetric ana-
lyses, providing data that cannot be obtained by conventional quality
control (Silveira et al., 2017). Yao et al. veriﬁed the dose distribution of
the VMAT technique for two simple and complex clinical cases by using
an N-isopropylacrylamide (NIPAM) gel dosimeter. For the simple case
of lung cancer, there were high gamma passing rates (between the gel
dosimeter and the TPS) for both the IMRT technique and the VMAT
technique. However, there were slightly lower gamma passing rates for
the complex case of larynx cancer than for the simple case for both the
IMRT technique and the VMAT technique (Yao et al., 2017).
Hepworth et al. investigated dose maps of inhomogeneities in BANG
gel and PAG dosimeters. In this study, the high- and low-density in-
homogeneities were designed to simulate the eﬀects of bone and air
cavities in the body, respectively, as well as their eﬀects on the ab-
sorbed dose during radiotherapy. They stated that an intrinsic problem
of the gel dosimeter is the inhibition of polymerization because of
dissolved oxygen. Therefore, they reported that more care is required in
the manufacture of gel dosimeters as well as in the preparation of the
inhomogeneity (Hepworth et al., 1999). Watanabe et al. used a cy-
lindrical phantom ﬁlled with BANG-3 gel to measure 3D dose dis-
tributions in inhomogeneous media (air gap and bone). In this study,
the eﬀects of MRI artifacts resulting from the presence of foreign ma-
terial within the phantom ﬁlled with the gel were observed. They found
that the geometric distortion of MRI is less than 2mm. Their results
showed that oxygen contamination and unintentional small air gaps in
the gel dosimeter can lead to a measured absorbed dose error of as large
as 10% near the interface between the gel dosimeter and the hetero-
geneity. They suggested that better quantiﬁcation of MRI artifacts and
further enhancement of the signal-to-noise ratio will help to decrease
the uncertainty of measured dose distributions (Watanabe et al., 2004).
Pourfallah et al. investigated the eﬀects of the presence of in-
homogeneities on diﬀerential dose volume histograms of single-shot
irradiations with a Gamma Knife unit by using EGSnrc simulation and a
PAGAT gel dosimeter. The results of measurement and simulation
showed that there are some diﬀerences between these two for very high
isodose levels. It seems that the discrepancies can be attributed to the
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diﬀusion of monomers in these regions (i.e., 70–80% isodose levels)
during gel irradiation and in the initial hours after irradiation. Never-
theless, their results demonstrated that the presence of bone and air
inhomogeneities in irradiation with the Gamma Knife unit can lead to
disturbances in the dose distribution and the PAGAT gel dosimeter is
able to detect these disturbances (Pourfallah et al., 2009). Ghasemi-
nejad et al. investigated the eﬀect of bone heterogeneity on dose dis-
tribution of small IMRT beamlets using a NIPAM gel dosimeter and
Monte Carlo simulation. Fairly close agreement was observed between
the gel dosimeter and Monte Carlo data to within± 3%. Moreover,
their results showed that with dose ﬂuctuations in the presence of bone
heterogeneity, the NIPAM gel dosimeter is able to evaluate the dose
variations at bony interfaces (Ghaseminejad et al., 2017).
Marques et al. analyzed the use of gold nanoparticles (AuNPs) in
kilovoltage radiotherapy by gel dosimetry. AuNPs were embedded in-
side a MAGIC-f gel dosimeter and irradiated with a 250-kV x-ray clin-
ical beam. The response of the MAGIC-f gel dosimeter to the beam was
speciﬁed by comparison of experimental and Monte Carlo–simulated
percentage depth dose curves. The MAGIC-f gel dosimeter showed a
linear response in the dose range from 0 to 10 Gy. The ﬁndings de-
monstrated good agreement (97%) between the gel dosimeter mea-
surements and simulated dose enhancements for all AuNP concentra-
tions studied (0.02, 0.05, and 0.10mM). Finally, they concluded that
gel dosimetry can be considered a suitable tool for dosimetric evalua-
tions of nanoparticle applications in radiotherapy (Marques et al.,
2010). Khadem-Abolfazli investigated the dose-enhancement eﬀect of
AuNPs MAGIC with agarose (MAGIC-A) gel in megavoltage radio-
therapy. Their ﬁndings showed that in the dose range from 0 to
600 cGy, the MAGIC-A gel dose response is linear and the dose re-
solution in this dose range is lower than 0.7 Gy. Furthermore, the
MAGIC-A gel dosimeter response (R2) was increased with the addition
of AuNPs. Moreover, they reported that a shielding eﬀect or self-ab-
sorption occurred at 0.2 and 0.4 mM (Khadem-Abolfazli et al., 2013).
Deyhimihaghighi et al. evaluated the feasibility of using PAGAT gel
combined with platinum nanoparticles (PtNPs) as a dose enhancer or
dosimeter to increase the optical density in MRI. They embedded var-
ious concentrations of PtNPs inside the PAGAT gel dosimeter and ir-
radiated it with 60Co. Their ﬁndings showed that in the presence of
PtNPs at a concentration of 1×10−2 mg/l, the optical density in-
creased by a factor of 27.10% (Deyhimihaghighi et al., 2014). Khosravi
et al. assessed the ability of a MAGIC-f gel dosimeter by Monte Carlo
simulation and experimental measurement to study the eﬀect of AuNPs
in prostate dose distributions. Their data showed that when external 18-
MV radiotherapy was used, the mean absorbed doses obtained with the
gel dosimeter and Monte Carlo simulation in prostate and in the pre-
sence of the AuNPs were 8% and 7% higher, respectively, than those in
the absence of AuNPs. Therefore, there was good agreement between
the gel dosimeter measurements and the Monte Carlo simulations. In
conclusion, they indicated that the gel dosimetry method can be used as
a reliable technique for evaluating the dose-enhancement caused by
AuNPs in external radiotherapy practices (Khosravi et al., 2015).
Fuse et al. used BANG-Pro gel as a dosimeter and a bolus compen-
sator in the near-surface buildup region in breast-conserving therapy.
The gel bolus is a water equivalent and can be constructed from dif-
ferent tissue compensators. Their results validated the usefulness of
BANG-Pro gel bolus in the near-surface buildup region to improve
treatment in the chest wall/whole breast (Fuse et al., 2015).
3.2.2. Brachytherapy
Brachytherapy is a type of radiotherapy in which one or many
sealed radioactive sources are placed at short distances from a tumor.
With this treatment modality, the tumor volume receives a high ra-
diation dose, while there is rapid dose fall-oﬀ in the surrounding normal
tissues (Khan and Gibbons, 2014). Gel dosimeters are able to acquire
steep dose gradients in 3D, and this property makes them very attrac-
tive for obtaining the dose distributions around brachytherapy sources.
Furthermore, these dosimeters integrate the dose delivery during the
treatment time, and the total dose distribution resulting from a moving
source can be measured (Baldock et al., 2010).
Chan et al. measured the 3D dose distribution of a 106Ru ophthal-
mological applicator using a BANG gel dosimeter. In this study, an eye
phantom made of the BANG gel was irradiated with the 106Ru source for
up to 1 h. Then isodoses and depth doses of the 106Ru eye plaque were
obtained. They suggested that the BANG gel dosimeter has the potential
to measure the 3D dose distributions around an ophthalmological ap-
plicator with relatively good accuracy and high spatial resolution (Chan
et al., 2000). Amin et al. measured dose proﬁles and orthogonal and
radial dose distributions for a 90Sr/90Y source (beta emitters) using a
PAG dosimeter and compared them with measurements made with
radiochromic ﬁlms. The phantom used in this study resembled a curved
coronary artery. The ﬁndings indicated that the PAG dosimeter can be
used to measure the dose distributions characterized by the American
Association of Physicists in Medicine for vascular brachytherapy
sources with high-resolution MRI (4.7 T). They stated that this tech-
nique is, however, limited to centers with high-resolution MRI. A fur-
ther disadvantage of using a PAG dosimeter is that stringent methods
must be used to exclude oxygen during the construction of the gel do-
simeter (Amin et al., 2003). Kipouros et al. evaluated the capability of
an N-vinylpyrrolidone-argon (VIPAR) gel dosimeter to provide 3D dose
distribution veriﬁcation in 192Ir prostate monotherapy. Their ﬁndings
showed that there are signiﬁcant diﬀerences between the calculated
and experimental 3D dose distributions for doses lower than 50% of the
prescribed dose, which could be because of the limited dose resolution
of the VIPAR gel–MRI method for this low dose gradient–low dose re-
gion. Furthermore, the measurements revealed distortions at distances
extending 1–1.5 mm around each catheter because of susceptibility
artifacts. However, for most remaining points, the deviations between
the calculated and the corresponding measured data were within the
adopted acceptance criterion of 5%/3mm. In conclusion, they reported
that the VIPAR gel–MRI procedure can be used for the experimental
veriﬁcation of the dose distribution in a brachytherapy application in-
volving source dwell positions and/or multiple catheters (Kipouros
et al., 2003). Giﬀord et al. compared Monte Carlo simulations around a
Fletcher-Suit-Delclos ovoid with a MAGIC gel dosimeter and radio-
chromic ﬁlm. This ovoid in intracavitary brachytherapy of cervical
cancer has shields that lead to reduction of the dose to the rectum and
bladder. The ﬁndings revealed that the MCNPX 2.5.c Monte Carlo code
can calculate the dose distribution accurately in the presence of the
ovoid shields, and that the radiochromic ﬁlm and the MAGIC gel do-
simeter can show the eﬀect of ovoid shields on the dose distribution
(Giﬀord et al., 2005). Marques et al. evaluated the response of a
MAGIC-f gel dosimeter around a 92Ir high-dose-rate (HDR) bra-
chytherapy source. In this study, an esophageal catheter was used to
guide the source. The results obtained with this gel dosimeter were
compared with those from PENELOPE Monte Carlo simulations and
ionization chamber measurements. There was a maximum diﬀerence of
3.10% between the Monte Carlo simulations and the gel dose mea-
surements at a radial distance of 18mm from the 92Ir source. Further-
more, the data demonstrated that the response of the MAGIC-f gel do-
simeter is strongly aﬀected by the dose rate and that diﬀerent
calibration should be used for areas near the source as well as for areas
with lower dose rates. Finally, they reported that the MAGIC-f gel do-
simeter can be successfully used to obtain accurate dose distributions
from HDR brachytherapy sources if the appropriate calibration is per-
formed (Marques et al., 2009). Fazli et al. compared the dosimetric data
between a TPS, a MAGIC-A gel dosimeter, and Monte Carlo simulation
in a heterogeneous nasopharynx phantom for HDR brachytherapy.
Their results revealed a predictable agreement between the data ob-
tained with the MAGIC-A gel dosimeter and the MCNP5 Monte Carlo
simulation, and discrepancies at diﬀerent distances were between 5.7%
and 7.4%. One of the reasons for these discrepancies could be due to the
simpliﬁcations in Monte Carlo simulation, but the most important
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reason could be practical errors in experimental dosimetry. In addition,
the MAGIC-A gel dosimeter had better resistance against temperature
increases; however, increase of the temperature is uncontrollable in
HDR brachytherapy because of the high dose gradients close to the
source. There was acceptable agreement between the data from the
MAGIC-A gel dosimeter and the results from the TPS calculations, and
discrepancies at diﬀerent distances were between 5.2% and 9.4%. The
sources of the discrepancies in this comparison could be related to the
variation in the calculations and the practical errors in the experimental
dosimetry (Fazli et al., 2013). Govi et al. speciﬁed the response of a
MAGAT gel dosimeter for breast brachytherapy applications through
two balloon applicators. The dose maps of balloons obtained from MRI
were compared with the TPS data. The gel dosimetry results showed
very good agreement (more than 95%) with the TPS data. Finally, they
concluded that the MAGAT gel dosimeter can be used as a reliable tool
for 3D dose veriﬁcation in balloon brachytherapy techniques (Govi
et al., 2013).
Khosravi et al. evaluated the eﬀects of AuNPs on the dose dis-
tribution for prostate in brachytherapy using MAGIC-f gel dosimetry
and Monte Carlo simulation. In this study, the tolerance criterion of
7%/7mm was used to analyze the data obtained with the gel dosimeter
and the Monte Carlo simulation, and high pass rates of 91.7% and
86.4% were achieved with and without AuNPs, respectively. The
comparison of gel dose measurements with Monte Carlo calculation
indicated good agreement, particularly in the region of the planning
target volume. In conclusion, they reported that the MAGIC-f gel do-
simeter could be recommended as a reliable tool for evaluating the dose
enhancement caused by various concentrations of AuNPs in bra-
chytherapy (Khosravi et al., 2016).
3.2.3. Boron neutron capture therapy
BNCT is a targeted radiotherapy based on the nuclear capture that
occurs when 10B (nonradioactive) is irradiated with thermal neutrons
(energies less than 0.025 eV). Following the interaction, high linear
energy transfer (LET) products (alpha particles and recoiling 7Li nuclei)
are produced (Farhood and Ghorbani, 2015; Khosroabadi et al., 2016).
These products deposit their energies in the range of 5–9 µm, which
corresponds to the diameter of a cell (Cerullo et al., 2004). Several
studies have been conducted using gel dosimeters in BNCT dosimetry
because of their advantages, such as the tissue equivalence of the gel
dosimeter at these energies, and also its ability to separate the com-
ponents of the dose (Ibbott, 2004).
Wojnecki et al. evaluated performance of A-150 plastic and PAG
dosimeters as substitutes for brain tissue in comparison with standard
phantom materials such as water and poly(methyl methacrylate). Their
ﬁndings indicated that the PAG dosimeter presents good simulation of
radiation transport in the brain, with discrepancies from the real brain
of 10.8%, 5.1%, and 9.4% at a depth of 50mm for gamma dose, epi-
thermal neutron, and thermal neutron ﬂuence dose distributions, re-
spectively. Finally, they reported that the PAG dosimeter can be con-
sidered as a promising substitute for brain tissue, and that it can, as a
dosimeter, provide a 3D map of the dose distribution delivered by the
epithermal neutron beam (Wojnecki and Green, 2001). Uusi-Simola
et al. studied the relative dose response of a BANG-3 gel dosimeter in
epithermal neutron irradiation. The elemental composition and density
of the BANG-3 gel dosimeter closely matches those of International
Commission on Radiation Units and Measurements (ICRU) 44 brain
tissue. In epithermal neutron irradiation, the response (R2) of the gel
dosimeter was linearly proportional to the total absorbed dose calcu-
lated by the DORT code in ICRU adult brain tissue. This data revealed
that the BANG-3 gel dosimeter can be a suitable tool to verify the re-
lative dose distribution of epithermal neutron beams regardless of the
LET-dependent response of the gel dosimeter. Moreover, they stated
that the presence of neutron-absorbing boron inside Pyrex glass causes
it to be less suitable in neutron beams as a container material. Finally,
the results revealed the potential of the BANG-3 gel dosimeter in the
dosimetry of epithermal neutron beams (Uusi-Simola et al., 2003).
Bavarnegin et al. investigated the ability of a NIPAM gel dosimeter to
provide the dose distribution resulting from BNCT. In this study, a head
phantom ﬁlled with the gel was irradiated with the BNCT beam line.
The ﬁndings demonstrated that the NIPAM gel dosimeter as a lower-
toxicity and tissue-equivalent gel dosimeter is an appropriate tool for
determining the 3D dose distribution resulting from BNCT. Further-
more, they stated that this gel dosimeter can be a reliable tool in
comparison with conventional BNCT dosimetric methods and can be a
useful tool in dosimetric veriﬁcation of BNCT planning because of its
abilities to record the 3D dose distribution with high spatial resolution
(Bavarnegin et al., 2017). Khajeali et al. measured the dose distribution
resulting from BNCT of shallow brain tumors with a NIPAM gel dosi-
meter. For this purpose, two poly(methyl methacrylate) cylinder
phantoms were applied to irradiate the gel dosimeters in front of the
BNCT beam. One of the phantoms was ﬁlled with only NIPAM gel and
the other one included about 20ml of NIPAM gel with 30 ppm of 10B
embedded in the gel dosimeter at a depth of 1 cm from the phantom
wall. The results showed an 18% increased dose in the region con-
taining 10B compared with the pure NIPAM gel. Finally, they concluded
that the NIPAM gel dosimeter can be used in dosimetric veriﬁcation of
BNCT planning (Khajeali et al., 2017).
4. Discussion
The irradiation techniques used in radiotherapy need reliable and
proper dosimetry, acceptable precision, high-resolution measurements
of 3D dose distribution, and veriﬁcation of the TPS and TPS-generated
plans for irradiation of tumors (Kozicki et al., 2017). As stated by
Podgorsak, gel dosimetry systems are accurate 3D dosimeters
(Podgorsak, 2005). A spider plot as presented by Oldham et al. (2003) is
an excellent form for comparison of gel dosimetry systems with con-
ventional dosimetry systems (Fig. 2).
This graphical presentation shows the relative performance of dif-
ferent dosimetry systems such as ﬁlm, ionization chambers, thermo-
luminescent dosimeters, and gel dosimeters by considering the para-
meters of volume measured, cost, accuracy, spatial resolution, three-
dimensionality, time required for the measurement, and energy de-
pendence. Compared with other detectors, gel dosimeters are favorable
Fig. 2. Spider plot presented by Oldham et al. (2003) comparing several
common dosimetry systems. TLD, thermoluminescent dosimeter. Reproduced
with permission from Oldham.
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in most properties, including their volumetric nature, relative accuracy,
high resolution, inherent three-dimensionality, and beam energy in-
dependency over much of the signiﬁcant beam energy range.
Some studies have been conducted recently in the ﬁelds of devel-
opment and optimization of gel compositions (toxicity, melting point,
gelling agents other than gelatin, etc.) (Senden et al., 2006; Fong et al.,
2001; Fernandes et al., 2008; Pavoni and Baﬀa, 2012; Hill et al., 2002;
Abtahi and Abandansari, 2017), readout systems of gel dosimeters
(Cheng et al., 2011; Papadakis et al., 2010; Watanabe and Kubo, 2011;
Wuu and Xu, 2011), dosimetric characteristic improvements (Sedaghat
et al., 2011a, 2011b; Chiang et al., 2013; Vandecasteele et al., 2011),
and investigation of the response of polymer gel dosimeters to diﬀerent
beams (gamma, proton, carbon, electron, and neutron beams) (Wuu
et al., 2002; Trapp et al., 2004; Gopishankar et al., 2012; Moutsatsos
et al., 2009; Novotný et al., 2002; Gustavsson et al., 2004; Zeidan et al.,
2010; Da Silveira et al., 2011; Pianoschi et al., 2010; Bartesaghi et al.,
2009; Gambarini et al., 2010; Uusi-Simola et al., 2007).
For clinical applications, it is necessary to investigate the accuracy,
dose resolution, reproducibility, and sensitivity of polymer gel dosi-
meters and also their response to beam energy, dose rate, etc. In the
following sections, some dosimetric and structural characteristics of the
polymer gels are presented. In addition, the properties of diﬀerent
polymer gel dosimeters used in clinical applications in radiotherapy are
discussed.
4.1. Accuracy
Both spatial and dosimetric accuracy of polymer gel dosimeters
must be considered in the ﬁnal response of a gel dosimetry experiment.
When the spatial dose distribution is measured, theoretically it is im-
possible to distinguish spatial and dosimetric errors from each other
(Baldock et al., 2010). The gamma index deﬁned by Low et al. (1998)
can be used to encompass both the spatial and the dosimetric perfor-
mance of gel dosimeters in one parameter. Diﬀerent sources can result
in loss of accuracy, as explained in detail by Baldock et al. (2010)
By evaluating the studies listed in Table 1, we found that most
polymer gel dosimeters have suﬃcient accuracy, considering diﬀerent
acceptance criteria in various studies. As stated by Baldock et al. (2010)
the basic problem in assessment of the ﬁnal accuracy of the dose maps
provided by gel dosimeters is that there is no gold standard for com-
parison of the 3D dose distribution. For evaluation of the accuracy of
gel dosimeters, the doses obtained with them are mostly compared with
doses obtained with the most reliable dosimeters, which use a certain
spatial dimension. For example, in 1D, percentage depth dose or dose
proﬁles obtained with gel dosimeters can be compared with those ob-
tained with a diamond detector or an ionization chamber (De Deene
et al., 1998; Haraldsson et al., 2000). In 2D, ﬁlm dosimetry is a suitable
tool for evaluating the accuracy of gel dosimeters (De Deene et al.,
2000; Pappas et al., 2001). In 3D, most comparisons have been per-
formed with a TPS (Ibbott et al., 1997; Grebe et al., 2001; Ramm et al.,
2000), as the treatment plan veriﬁcation is the most important appli-
cation of gel dosimeters in quality assurance of radiotherapy so far.
The factors aﬀecting the accuracy can be categorized in two groups:
(a) dosimetric factors such as chemical stability, spatial stability, en-
ergy-dependent response, dose rate–dependent response, temperature
dependency, tissue equivalency, recipient wall eﬀects, voxel shape
imaging artifacts, etc. that can lead to deviations between the pre-
scribed dose and the measured dose; and (b) spatial deviations such as
phantom positioning error, volumetric contraction of the gel dosimeter,
and imaging artifacts that can cause discrepancies in the spatial dis-
tribution of the delivered dose (Baldock et al., 2010).
4.2. Dose resolution
The concept of dose resolution introduced by Baldock et al. (2001)
is used to estimate the intrinsic dosimetric precision in terms of
scanning signal-to-noise ratio and dose sensitivity. The minimal se-
paration of two detectable absorbed doses with a certain level of con-
ﬁdence, p, is called dose resolution. This is dependent on both the signal
acquisition system and the dosimeter itself, and is independent of sto-
chastic variations in dose delivery, chemical concentrations, or the
calibration procedure. It is notable that the dose resolution can be used
as the criterion to compare and optimize various types of gel dosimeters
for a certain set of scanning parameters. In conclusion, the concept of
dose resolution is very practical in helping the optimization of the MRI
sequence, as the ﬁndings may diﬀer if various scanning parameters are
applied.
Hilts et al. evaluated the response of a PAG dosimeter using x-ray
CT. Their results showed that the dose resolution of the PAG dosimeter
is about 50 cGy for an image thickness of 1 cm. Therefore, they reported
that despite the low dose resolution, the X-ray CT technique provides
accurate localization of high dose gradients such as those seen in ste-
reotactic radiosurgery (Hilts et al., 2000). Trapp et al. investigated the
dose response of acrylamide-based gel dosimeters with diﬀerent com-
positions using X-ray CT. They reported that the minimum dose re-
solution is about 1 Gy for low doses, as the dose resolution deteriorates
at higher doses, especially in the several gray doses. Furthermore, their
ﬁndings showed that the dose resolution is optimal for gel dosimeters
with 3% acrylamide, 3% N,N′-methylenebisacrylamide (Bis), 5% ge-
latin, and 89% water (Trapp et al., 2001). Hurley et al. investigated the
dose response of a MAGIC gel dosimeter around point-source irradia-
tion from a brachytherapy source. They reported that the dose resolu-
tion of this gel dosimeter is lower than 0.5 Gy for the 0–10 Gy dose
range (Hurley et al., 2006). Crescenti et al. changed the relative amount
of the components of the MAGIC gel dosimeter to provide linear and
steep dose-response relationships. Their ﬁndings revealed a mean dose
resolution of less than 0.13 Gy for IMRT and a dose resolution from 0.97
to 2.15 Gy for radiosurgery in 5 and 40 Gy doses, respectively
(Crescenti et al., 2007). Cho et al. assessed the dose response of a
normoxic poly(methacrylic acid) gel dosimeter using optimal CT. They
reported that the relative dose resolution (at the 95% conﬁdence level)
is 18.4%, which is higher than that of PAG dosimeters (between 4.8%
and 17.5% depending on the composition). Moreover, they mentioned
that MAGAT and PAGAT gel dosimeters have relative dose resolutions
of 7.9% and 11.8–14.6%, respectively (Cho et al., 2012). Khadem-
Abolfazli et al. investigated the dose response of a MAGIC-A gel dosi-
meter. Their ﬁndings showed that the dose resolution for doses less
than 5 Gy is less than 0.7 Gy and for higher doses increases to 1 Gy
(Khadem-Abolfazli et al., 2013). Silveira et al. measured the dose re-
solution of a MAGIC-f gel dosimeter and reported that it is 0.2 Gy (at the
95% conﬁdence level) (Silveira et al., 2017). Jirasek et al. proposed a 2-
propanol-based gel dosimeter formulation (NIPAM monomer) with a
high %T (T expresses the total mass fraction of monomers used in the
recipe) for x-ray CT gel dosimetry. Their results showed that 16%T gel
dosimeters imaged with X-ray CT have lower dose resolutions than
previous formulations. At the 67% conﬁdence level and for the 16%T
gel dosimeter, the dose resolution was in the 0.2–0.3 Gy range over a
0–30 Gy dose range (i.e., dose resolution less than 0.9 Gy at the 95%
conﬁdence level). Also, they reported that the dose resolution in un-
ﬁltered images is about 0.1 Gy higher than in ﬁltered images (Jirasek
et al., 2010). Kipouros et al. assessed the dynamic dose range and the
linear dose response of a VIPAR-based gel dosimeter. Their ﬁndings
demonstrated that the VIPAR gel dosimeter has a dose resolution of 2%
at a dose of 25 Gy. Furthermore, they stated a PAG dosimeter has lower
dose resolution, as it usually shows greater dose sensitivity in com-
parison with a VIPAR gel dosimeter. Also, they mentioned that aver-
aging and/or smoothing gel dosimeter data can lead to improvement of
dose resolution (Kipouros et al., 2001). Kozicki et al. evaluated the dose
response of an improved VIPAR gel dosimeter. The dose resolution of
this gel dosimeter in the whole linear dose range was from 0.65 to
1.35 Gy. Furthermore, they reported that the dose resolution obtained
in their study is lower than that of a high %T NIPAM gel dosimeter and
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also that it seems to be comparable with that of a 50%C (C expresses the
mass fraction of the monomers used in the recipe that is crosslinker),
6%T NIPAM gel dosimeter for the 10–30 Gy dose range (Kozicki et al.,
2017). Abtahi and Abandansari investigated the properties of a polymer
gel dosimeter with cross-linked poly(vinyl alcohol) as a gelatinous
matrix. Their ﬁndings demonstrated that the dose resolution increases
with increasing absorbed dose. Furthermore, the minimum and max-
imum dose resolution (at the 95% conﬁdence level) for this gel dosi-
meter were 0.085 and 0.190 Gy, respectively, which were related to the
lowest (30 Gy) and highest (45 Gy) absorbed dose in the dynamic range
evaluated (Abtahi and Abandansari, 2017).
4.3. Sensitivity
For a polymer gel dosimeter, the sensitivity is deﬁned as the slope of
the linear part of the dose response, which is named the response-dose
sensitivity (De Deene et al., 2006). Similarly to the dose resolution,
sensitivity is a useful quantity to compare various gel formulations and
MRI techniques. This quantity aﬀects the minimum detectable dose,
dose resolution, and calibration error estimation (Abtahi et al., 2014;
Baldock et al., 2001; De Deene, 2004).
Baldock et al. reported that the mean sensitivity of a PAG dosimeter
in the range up to 10 Gy is 0.03 Gy−1 s−1 (Baldock et al., 1998). It is
notable that diﬀerent concentrations of both gelatin and acrylamide
and Bis lead to diﬀerences in sensitivity (Baldock et al., 1996a;
Maryanski et al., 1997; Audet et al., 1996). Lepage et al. found that
depending on the monomers used in the PAG formulation, the dose
sensitivities change in the range from 0.33 to 1.19 Gy−1 s−1 (Lepage
et al., 2001). Pourfallah et al. showed that for dose ranges of 0–20 Gy
and 20–40 Gy, the R2 dose sensitivity of PAGAT gel is 0.09 and
0.08 Gy−1 s−1, respectively (Pourfallah et al., 2012). A chief deﬁciency
of acrylamide-based gel dosimeters is their relatively low sensitivity. In
this regard, several researchers increased the sensitivity of the acryla-
mide-based polymer gels. Abtahi et al. increased the sensitivity of a
PAGAT gel dosimeter by adding urea and glucose, and the new for-
mulation was called PAGATUG. They reported that the R2 sensitivity of
the PAGATUG gel dosimeter in comparison with a PAGAT gel dosimeter
was increased by a factor of about 2.6 (0.509 Gy−1 s−1 vs. 0.192 Gy−1
s−1) (Abtahi et al., 2014). Yoshioka et al. reported that the dose sen-
sitivity of a polyacrylamide-based gel dosimeter was increased by ad-
dition of sucrose (Yoshioka et al., 2010). Fong et al. indicated that the
dose sensitivities of a MAGIC gel dosimeter in the 0–30 Gy range at
20MHz are 0.68, 0.52, and 0.30 Gy−1 s−1, respectively, when the
concentration of methacrylic acid is 3%, 6%, and 9%, respectively.
Furthermore, they showed that the dose sensitivities increased to 0.87,
0.57, and 0.31 Gy−1 s−1 at 85MHz (Fong et al., 2001). Hurley et al.
evaluated the response of a MAGAT gel dosimeter using MRI. The R2
dose sensitivity obtained for this gel dosimeter ranged from 1.65 to
8.18 Gy−1 s−1 for the diﬀerent concentrations of methacrylic acid and
gelatin used in the MAGAT gel formulation (Hurley et al., 2005).
Venning et al. presented the R2 dose response of a methacrylic acid,
gelatin, and ascorbic acid (MAGAS) gel dosimeter for doses up to 25 Gy.
Their results showed an R2 dose sensitivity of 0.50 Gy−1 s−1 (Venning
et al., 2005a). Fernandes et al. added 3% formaldehyde to a MAGIC gel
dosimeter formulation (MAGIC-f). The formaldehyde increased the
sensitivity of the MAGIC-f gel dosimeter by about 10% (1.05 Gy−1 s−1
vs. 0.95 Gy−1 s−1) (Fernandes et al., 2008). Pavoni and Baﬀa added
3.3% formaldehyde to a MAGIC gel formulation and showed increased
thermal stability of the gel dosimeter prepared. Their MAGIC-f gel do-
simeter irradiated with 60Co beams and 10MV beams had dose sensi-
tivities of 0.67 and 0.63 Gy−1 s−1, respectively (Pavoni and Baﬀa,
2012). Hayashi et al. evaluated the eﬀect of inorganic salt on the dose
sensitivity of a methacrylic acid–based gel dosimeter. They found that
the dose sensitivity of the methacrylic acid–based gel dosimeter was
enhanced by the addition of inorganic salts. They reported that the
slopes of the R2 dose response curves for the samples with 0.0, 0.5, and
1.0 M MgCl2 were 3.14, 5.56, and 8.93 Gy−1 s−1, respectively (Hayashi
et al., 2010). Abtahi et al. added agarose to the MAGIC gel formulation
(MAGIC-A). They indicated that the dose sensitivity of the MAGIC-A gel
dosimeter for gamma irradiation is 0.38 Gy−1 s−1, which decreased to
0.18 Gy−1 s−1 for thermal neutron irradiation (Abtahi et al., 2016).
Pantelis et al. reported a poly(ethylene glycol) diacrylate, Bis, and ge-
latin (PABIG) gel dosimeter with a dose sensitivity of 0.11 and
0.14 Gy−1 s−1 at 11 and 26 days after irradiation, respectively (Pantelis
et al., 2006). Pappas et al. irradiated VIPAR gel dosimeters in the dose
range from 0 to 12 Gy and then scanned them by MRI. The dose sen-
sitivity was 0.10 Gy−1 s−1 for this gel dosimeter. Furthermore, they
indicated that this dose sensitivity does not change with time and is not
reduced even when a boost dose of 2.5 Gy is used 15 days after the ﬁrst
irradiation (Pappas et al., 1999). Kozicki et al. improved the VIPAR gel
dosimeter by altering the concentrations of the N-vinylpyrrolidone and
Bis monomeric components in co-solvent solutions. They reported a
maximum dose sensitivity of 0.17 Gy−1 s−1 for the new gel dosimeter
by NMR measurements (Kozicki et al., 2017). Maryanski et al. reported
a linear dose response up to about 8 Gy for a BANG gel dosimeter, with
a dose sensitivity of 0.25 Gy−1 s−1 obtained by MRI (Maryanski et al.,
1994). Oldham et al. increased the comonomer concentration of a
BANG gel dosimeter (100% higher than in the dosimeter developed by
Maryanski et al. (1994), and concluded that the dose sensitivity in-
creased to 70% (Oldham et al., 1998). Koeva et al. reported the dose
sensitivities of NIPAM gel dosimeters for diﬀerent recipes. For example,
for a recipe of 6%T, %50 C, and without a co-solvent, the dose sensi-
tivity of the NIPAM gel dosimeter was 0.07 Gy−1 s−1, and for a recipe
of 10%T, 50%C, and with a co-solvent (2-propanol), it was 0.15 Gy−1
s−1. Increasing the solubility of Bis in NIPAM-based gel dosimeters by
addition of a co-solvent such as 2-propanol and glycerol leads to an
increase of dose sensitivity (Koeva et al., 2009). Chen et al. reported
that in the 0–12 Gy dose range, the dose sensitivity of a NIPAM gel
dosimeter was 0.11 Gy−1 s−1 (Chen et al., 2014). Hsieh et al. measured
the dose distribution for ﬁxed and moving irradiation targets. Their
ﬁndings showed that the mean dose sensitivities of ﬁxed and moving
NIPAM gel dosimeters are 0.136 and 0.137 Gy−1 s−1, respectively
(Hsieh et al., 2015). Farhood et al. (2018a) reported that in the 0–10 Gy
dose range, the dose sensitivity of a poly(2-acrylamido-2-methylpro-
pane sulfonic acid sodium salt) and gelatin (PASSAG) gel dosimeter is
between 0.13 and 0.15 Gy−1 s−1. To directly compare the dose sensi-
tivities of various polymer gel dosimeters with each another, the
aforementioned data are summarized in Table 2.
Several studies reported the dose sensitivity of polymer gel dosi-
meters by using X-ray CT (Hilts et al., 2000; Kozicki et al., 2017;
Brindha et al., 2004; Hill et al., 2005; Sellakumar et al., 2010; Shih
et al., 2017).
4.4. Reproducibility
An important factor that can inﬂuence the results obtained from a
dosimetric system is the reproducibility of the dose response. The re-
producibility of polymer gel dosimeters is classiﬁed in two groups: in-
trabatch reproducibility and interbatch reproducibility.
De Deene reported the intrabatch and interbatch reproducibility of
PAG dosimeters is equivalent to 0.9% and 0.08% of the total dose
range, respectively (De Deene, 2004). Cosgrove et al. investigated the
reproducibility of a PAG dosimeter and reported that response of this
dosimeter for the more than 50% isodose curves is very reproducible, as
the standard deviation on all the regions around the 50–90% isodose
curves was 6.4%. However, for the lower isodose curves, the variance
was larger (Cosgrove et al., 2000). Bayreder et al. investigated the dose
reproducibility of MAGAT for diﬀerent tetrakis(hydroxymethyl)phos-
phonium chloride concentrations. Their results demonstrated that the
dose reproducibility for voxel volumes of approximately
1.4×1.4× 2mm3 was better than 2% (Bayreder et al., 2006). Cho
et al. evaluated the dosimetric properties of normoxic poly(methacrylic
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acid) gel dosimeters using optimal CT. They reported that the re-
producibility of the gel dosimeters irradiated with 2 and 4 Gy was 2.0%
and 2.1%, respectively (Cho et al., 2012). Maryanski et al. (1994) re-
ported that the variation of the R2 dose response of a BANG gel dosi-
meter is reproducible and is less than 2%. Farajollahi et al. evaluated
the properties of a BANG gel dosimeter in low-dose-rate brachytherapy.
Their ﬁndings showed that the dose-response curves are reproducible
over the measured dose range (0–10 Gy), as they reported an intrabatch
reproducibility of within± 4% for the BANG gel dosimeter (Farajollahi
et al., 1999). Venning et al. reported an interbatch reproducibility of up
to 5% diﬀerence in the dose for a MAGAS gel dosimeter (Venning et al.,
2005a). Farajollahi et al. indicated that the dose response of a NIPAM
gel dosimeter is reproducible in the same and various batches of che-
mical. They reported that the intrabatch reproducibility and interbatch
reproducibility of NIPAM gel are 3% and 2%, respectively (Farajollahi
et al., 2014). Ghaseminejad et al. evaluated the reproducibility of the
absorbed dose response of a NIPAM gel dosimeter. Their ﬁndings
showed that the dose response is highly reproducible over the measured
dose range (0–12 Gy) and is within± 3% (Ghaseminejad et al., 2017).
4.5. Eﬀect of dose rate
An ideal dosimeter must be able to measure the 3D dose distribution
with a constant response irrespective of the dose rate. Given that the
dose rate is spatially dependent, it is necessary for any gel dosimeter
that its response be relatively insensitive to the dose rate. The dose
rate–dependent response of polymer gel dosimeters is dependent on the
type of polymer gel.
Several studies have investigated the eﬀect of the dose rate de-
pendency of diﬀerent polymer gel dosimetry systems. Novotny et al.
evaluated the dependence of a BANG-2 gel dosimeter on dose rates of
80, 160, 240, 320, and 400 Monitor unit (MU)–min−1. The results
showed that there is no trend in the dependence of the BANG-2 gel
dosimeter dose sensitivity on the dose rate for both electron beams and
photon beams (Novotny et al., 2001). Senden et al. evaluated the dose
rate dependency response of various polymer gel dosimeters (NIPAM/
Bis, diacetone acrylamide [DAAM]/Bis, PAGAT, and N-vinylformamide
[NVF]/Bis) at dose rates of 55 and 272 cGymin−1. They showed that
the dose rate does not remarkably aﬀect the response of the polymer
gels irradiated with 15 and 50 Gy. Furthermore, their ﬁndings revealed
the NIPAM/Bis gel dosimeter has lower dependency on the dose rate
than the PAGAT gel dosimeter (Senden et al., 2006). Bayreder et al.
investigated the dose rate dependency of a MAGAT gel dosimeter in
low-, medium-, and saturation-dose regions. They showed that the
presence of tetrakis(hydroxymethyl)phosphonium chloride in MAGAT,
as an oxygen scavenger, results in high sensitivity to the dose but that
the dose response ﬁrmly depends on the dose rate in the high- and
medium-dose regions. Furthermore, only at low doses (2 Gy) was a dose
rate dependence not found. So, they concluded that in dosimetry with
MAGAT gel, tetrakis(hydroxymethyl)phosphonium chloride should be
used only in the low-dose region away from saturation (Bayreder et al.,
2006). In studies by Adinehvand et al. and Azadbakht et al., the eﬀects
of dose rates of 80, 160, 240, 320, 400, and 480 cGymin−1 on the
response of MAGIC-A and PAGAT gel dosimeters in electron beams
were investigated. The data showed that there is no trend in the R2
dependency on the mean dose rate (Adinehvand et al., 2008; Azadbakht
et al., 2009). Zehtabian et al. evaluated the dose rate–dependent re-
sponse of a PAGAT gel dosimeter at low dose rates. Their results
showed that the response of the PAGAT gel dosimeter would be aﬀected
by oxygen. They reported that oxygen diﬀusion through plastic vials
would aﬀect the response of a gel dosimeter for dose rates lower than
2 Gy h−1. Therefore, they recommended that glass vials be used instead
of plastic vials for dosimetry purposes for low-dose-rate sources.
However, when plastic vials or phantoms are used for such sources they
should be kept in oxygen-free conditions. Furthermore, their ﬁndings
showed that the use of plastic vials does not have a considerable eﬀect
on the PAGAT gel dosimeter response for dose rates of 2 Gy h−1 or more
(Zehtabian et al., 2012). Farajollahi et al. investigated the dependency
of the response of a NIPAM gel dosimeter on the dose rate. Their
ﬁndings showed that the response of the NIPAM gel dosimeter is not
aﬀected by the dose rate (Farajollahi et al., 2014). Waldenberg et al.
characterized the dose rate dependency of a NIPAM gel dosimeter for
dose rates of 100, 300, and 600MUmin−1. They found that the dose
response of the NIPAM gel dosimeter is dependent on the dose rate
(Waldenberg et al., 2017). Farhood et al. evaluated the dependency of
the response of a PASSAG gel dosimeter on dose rates of 100, 200, 300,
and 400 cGymin−1, and reported that the R2 dose response and sen-
sitivity of this gel dosimeter are not aﬀected by the dose rate (Farhood
et al., 2018a).
4.6. Eﬀect of beam energy
One of the physical factors that can aﬀect the gel dosimeter response
is the beam energy, and this needs to be investigated individually.
Maryanski et al. reported that a BANG-2 gel dosimeter has a linear
dose response with beam energy independency for a range of photon
and electron beams (Maryanski et al., 1996a, 1996b). In studies by
Farajollahi et al. and Baldock et al., BANG gel dosimeters were irra-
diated with photon energies of 300 kV, 660 keV, 1.25MeV, 6MV, 8MV,
and 16MV and electron energies of 5, 7, 9, 12, 15, 17, and 20MeV.
They concluded that the dose response of the BANG gel dosimeter is
independent of electron and photon energies (Farajollahi et al., 1999;
Baldock et al., 1996b). Novotny et al. investigated the dependency of
BANG-2 gel dosimeter sensitivity on X-ray photon energies of 4, 6, and
18MV and electron energies of 9, 12, 16, and 20MeV. Their results
demonstrated a trend in the dependence of the gel dosimeter sensitivity
on X-ray photon and electron energies, as the gel dosimeter sensitivity
has a decreasing trend with increasing electron or photon energy
(Novotny et al., 2001). Pantelis et al. and Venning et al. evaluated the
beam energy dependence of several normoxic polymer gel dosimeters.
Table 2
The dose sensitivity of various polymer gel dosimeters.
Gel type Linear dose range
(Gy)
Dose sensitivity (Gy−1
s−1)
Reference
PAG 0–10 0.03 Baldock et al. (1998)
PAGAT 0–20 and 20–40 0.09 and 0.08 Pourfallah et al.
(2012)
PAGATUG 1.5–3.5 0.51 Abtahi et al. (2014)
MAGIC 0–30 0.30–0.87 Fong et al. (2001)
MAGAT – 1.65–8.18 Hurley et al. (2005)
MAGAS 0–25 0.50 Venning et al.
(2005a)
MAGIC-f 0–10 1.05 Fernandes et al.
(2008)
MAGIC-A 1–12.5 0.38 Abtahi et al. (2016)
PABIG 0–15 0.11 Pantelis et al. (2006)
VIPAR 0–12 0.10 Pappas et al. (1999)
BANG 0–8 0.25 Maryanski et al.
(1994)
NIPAM 0–21 0.07–0.15 Koeva et al. (2009)
PASSAG 0–10 0.13–0.15 Farhood et al.
(2018a)
MAGAS, methacrylic acid, gelatin, and ascorbic acid; MAGAT, methacrylic acid,
gelatin, and tetrakis(hydroxymethyl)phosphonium chloride; MAGIC, me-
thacrylic acid, ascorbic acid, gelatin, and copper; MAGIC-A, methacrylic acid,
ascorbic acid, gelatin, copper, and agarose; MAGIC-f, methacrylic acid, ascorbic
acid, gelatin, copper, and formaldehyde; NIPAM, N-isopropylacrylamide;
PABIG, poly(ethylene glycol) diacrylate, N,N ′-methylenebisacrylamide, and
gelatin; PAG, polyacrylamide gel; PAGAT, polyacrylamide, gelatin, and tetrakis
(hydroxymethyl)phosphonium chloride; PAGATUG, polyacrylamide, gelatin,
and tetrakis(hydroxymethyl)phosphonium chloride, urea, and glucose;
PASSAG, poly (2-acrylamido-2-methylpropane sulfonic acid sodium salt) and
gelatin; VIPAR, N-vinylpyrrolidone-argon.
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The gel dosimeters used in these studies were BANG-1, BANG-2, BANG-
3, VIPAR, PABIG, MAGIC, MAGAS, and MAGAT gel dosimeters. They
reported that the dose response of these normoxic polymer gel dosi-
meters is independent of beam energy over the wide range from
100 keV to 10MeV (Pantelis et al., 2004; Venning et al., 2005b). De
Deene et al. assessed the dose response of a normoxic methacrylic
acid–based gel (nMAG) dosimeter and acrylamide-based gel (PAG and
normoxic PAG [nPAG]) dosimeters for photon energies of 6 and 25MV.
They concluded that there is no change in the dose response of the PAG
and nPAG dosimeters, but a small change was found with increasing
photon energy for the nMAG dosimeter (De Deene et al., 2001, 2006).
Adinehvand et al. investigated the dependency of the response of a
MAGIC-A gel dosimeter on electron energies of 4, 6, 12, and 18MeV.
They found that the sensitivity of the MAGIC-A gel dosimeter is de-
pendent on the electron energy, as the gel dosimeter response increased
with increasing electron energy (Adinehvand et al., 2008). Sathiyaraj
et al. evaluated the energy dependency of a MAGAT gel dosimeter on
photon energies of 6 and 10MV. Their ﬁnding showed that the energy
dependency of the MAGAT gel dosimeter is not signiﬁcant (Sathiyaraj
and Samuel, 2018). Sellakumar et al. assessed the beam energy de-
pendency of a PAGAT gel dosimeter on photon energies of 1.25MeV,
6MV, and 15MV and electron energies of 6, 9, 12, 15, 18, and 21MeV.
They reported that the dependence of the PAGAT gel dosimeter sensi-
tivity on various electron and photon energies is insigniﬁcant
(Sellakumar et al., 2010). Farajollahi et al. investigated the dose re-
sponse of a NIPAM gel dosimeter on photon energies of 9MV and
1.25MeV. Their results revealed that the dose response of the NIPAM
gel dosimeter is not dependent on beam energy (Farajollahi et al.,
2014). Shih et al. assessed the dose response of an n-NIPAM gel dosi-
meter on electron energies of 6, 9, and 12MeV. Their data showed that
the energy dependency of this gel dosimeter is negligible as the sensi-
tivity variation for diﬀerent electron energies was less than 2% (Shih
et al., 2017). Farhood et al. (2018a) evaluated the dependency of the
response of a PASSAG gel dosimeter on photon energies of 6 and 18MV
and reported that the R2 dose response and sensitivity of this gel do-
simeter are not aﬀected by photon energy.
4.7. Toxicity
One of the main limitations of polymer gel dosimeters for use in
routine clinical applications is the problem of toxicity of monomers
(Waldenberg et al., 2017).
The use of noxious monomers such as acrylamide and Bis is a con-
cern among researchers. Therefore, acrylamide-based gel dosimeters
such as PAG, PAGAT, and similar gels must be prepared, used, and
disposed of with great care. Acrylamide is a serious neurotoxin and a
suspected human teratogen and carcinogen that is easily absorbed via
the skin. The oral median lethal dose (LD50) of acrylamide is approxi-
mately 124mg kg−1 in rats (Sigma-Aldrich, 2013a). In this regard,
several researchers have attempted to discover new monomers with
lower toxicity.
Senden et al. replaced very toxic acrylamide with less harmful
DAAM, NVF, and NIPAM. Their results showed that the dose response
of a NIPAM gel dosimeter is comparable to that of a PAGAT dosimeter
in terms of low dependency on the dose rate and irradiation tempera-
ture and high dose sensitivity. In addition, the dose response of NIPAM
revealed a linear trend over a higher dose range than that of PAGAT.
Two other gel dosimeters (DAAM and NVF gel dosimeters) had re-
markably lower dose sensitivities (Senden et al., 2006). It is noteworthy
that the NIPAM gel dosimeter has an oral LD50 of 375mg kg−1, and so
NIPAM is still a toxic monomer (Sigma-Aldrich, 2013b). However,
NIPAM is very expensive, which increases the total cost of gel dosimeter
production. Pappas et al. introduced a VIPAR gel dosimeter. This gel
dosimeter contains N-vinylpyrrolidone, which has an oral LD50 of
1022mg kg−1 (Pappas et al., 1999). However, N-vinylpyrrolidone is
suspected of having carcinogenic eﬀects (BASF, 2015). Abtahi
introduced a new polymer gel dosimeter (PAMPSGAT gel dosimeter). In
this gel dosimeter, the polyacrylamide monomer, which is extremely
toxic, is replaced by the monomer 2-acrylamido-2-methylpropane sul-
fonic acid (Abtahi, 2016), which is less toxic, with an oral LD50 of
1838mg kg−1, and also cost-eﬀective (Sigma-Aldrich, 2014). This
monomer showed remarkably lower toxicity compared with acryla-
mide, NIPAM, and N-vinylpyrrolidone. On the other hand, the use of
hydroquinone, with an oral LD50 of 320mg kg−1, as a free-radical
scavenger in polymer gel dosimeters is considered another toxic source,
and this substance has been not used in PAMPSGAT gel dosimeters
(Abtahi, 2016). Moreover, 2-acrylamido-2-methylpropane sulfonic acid
has shown a negative response in carcinogenicity tests (Sigma-Aldrich,
2014). Farhood et al. recently developed a new polymer gel dosimeter
with negligible toxicity. In this study, 2-acrylamido-2-methylpropane
sulfonic acid sodium salt was used instead of acrylamide in a PAGAT gel
dosimeter, and the new formulation was called PASSAG; that is, poly(2-
acrylamido-2-methylpropane sulfonic acid sodium salt) and gelatin.
The monomer used in the PASSAG gel dosimeter is a safe substance
with LD50> 16,000mg kg−1 and negative genetic toxicity and carci-
nogenicity test results and is eco-friendly (Farhood et al., 2018b).
4.8. Melting point
Increasing the melting point of the polymer gel dosimeters is ne-
cessary for their use in higher-temperature conditions, such as a reactor
thermal column, or to allow convenient gel preparation in practical
environments. In addition to radiotherapy modalities with gamma ra-
diation, the improved gel dosimeters can be used for dosimetric pur-
poses in treatment modalities with thermal/epithermal neutrons such
as BNCT.
Recently, several researchers recommended substances for in-
creasing the melting point (Fernandes et al., 2008; Pavoni and Baﬀa,
2012). Pavoni et al. used formaldehyde to increase the melting point of
a MAGIC gel dosimeter (Fernandes et al., 2008; Pavoni and Baﬀa,
2012). One shortcoming of conventional methacrylic acid–based gel
dosimeters such as MAGIC gel dosimeter is their low melting point.
MAGIC gel dosimeters have a melting point of about 25 °C, which is not
suitable for use in higher-temperature conditions. They reported that
formaldehyde added to MAGIC gel (MAGIC-f) increases its melting
point from 25 to 69 °C (Fernandes et al., 2008; Pavoni and Baﬀa, 2012).
However, formaldehyde is very toxic and the toxicity of the MAGIC-f
polymer gel is greater than that of the MAGIC polymer gel. Abtahi et al.
added agarose to the MAGIC gel formulation to increase its melting
point (agarose is nontoxic). Addition of agarose increased the melting
point to 60 °C without adding any extra toxicity (Abtahi et al., 2016).
5. Conclusion
The propose of gel dosimetry in clinical applications is to obtain an
integrated 3D dose distribution in anthropomorphic phantoms. In this
regard, diﬀerent polymer gel dosimeters have been used by researchers.
In the current work, most gel dosimeters studied showed acceptable
dose accuracy as a 3D dosimeter with high resolution.
Among the important features of polymer gel dosimeters for clinical
applications are the accuracy, dose resolution, reproducibility, and
sensitivity and also the dependence of their response to beam energy,
dose rate, etc. Acrylamide-based gel dosimeters are highly toxic, and
their sensitivity and dose resolution are relatively low and high, re-
spectively. However, their dose response is not aﬀected by dose rate
and beam energy. Methacrylic acid–based gel dosimeters have high
dose sensitivity and lower toxicity, while their dose response is beam
energy dependent. NIPAM gel dosimeters have low dose resolution, but
their sensitivity is lower and they are relatively toxic. Therefore, it is
diﬃcult to judge which is the best gel dosimeter to use in the clinic
because each polymer gel dosimeter has its advantages and limitations.
Researchers are attempting to develop and optimize polymer gel
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dosimeters. In this regard, several polymer gel dosimeters have recently
been introduced; for example, PASSAG (negligible toxicity), PVA, Bis,
Acrylamide and THPC (PVABAT) (lower dose resolution), and MAGIC-A
(increased melting point without imposing any additional toxicity) gel
dosimeters. However, the other dosimetric characteristics of the new
polymer gel dosimeters for use in the clinic should be investigated.
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